Treatment of methicillin-resistant Staphylococcus aureus (MRSA): updated guidelines from the UK | Zendy

Nicholas M. Brown | Zendy; Anna L. Goodman | Zendy; Carolyne Horner | Zendy; Abi Jenkins | Zendy; Erwin Brown | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Treatment of methicillin-resistant Staphylococcus aureus (MRSA): updated guidelines from the UK

Author(s) -

Nicholas M. Brown,

Anna L. Goodman,

Carolyne Horner,

Abi Jenkins,

Erwin Brown

Publication year - 2021

Publication title -

jac-antimicrobial resistance

Language(s) - English

Resource type - Journals

ISSN - 2632-1823

DOI - 10.1093/jacamr/dlaa114

Subject(s) - staphylococcus aureus , methicillin resistant staphylococcus aureus , microbiology and biotechnology , medicine , biology , bacteria , genetics

These evidence-based guidelines are an updated version of those issued in 2008. They have been produced following a review of the published literature (2007–18) pertaining to the treatment of infections caused by MRSA. The guidelines update, where appropriate, previous recommendations, taking into account changes in the UK epidemiology of MRSA, ongoing national surveillance data and the efficacy of novel anti-staphylococcal agents licensed for use in the UK. Emerging therapies that have not been licensed for use in the UK at the time of the review have also been assessed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research